Lifetime incidence of Alzheimer's disease (AD) in Down syndrome (DS) exceeds 90%. In adults with and without DS, low moderate-to-vigorous physical activity (MVPA) and obesity have independently been associated with AD. Research across other disease conditions indicates MVPA may attenuate some negative consequences of obesity.
Objective
To evaluate the potential joint association of obesity and MVPA on cognitive function in adults with DS.
Methods
Seventy-five adults with DS (age 39.1 years, 46.7% female) enrolled in the Alzheimer Biomarker Consortium-Down Syndrome (ABC-DS) study and completed a 7-day accelerometer protocol. Cognitive function was assessed using the ABC-DS cognitive battery. Participants were categorized with Obesity (body mass index (BMI) ≥ 30 kg/m2) or No Obesity (BMI < 30 kg/m2). A median split of MVPA was then used to create four groups: No Obesity/High PA (n = 18), No Obesity/Low PA (n = 16), Obesity/High PA (n = 20), and Obesity/Low PA (n = 21). Linear models were used to compare cognitive function across groups.
Results
The Obesity/High PA group performed better than the No Obesity/Low PA group for episodic memory (β = 4.86, p = 0.009), executive functioning (β = 3.07, p = 0.013), and dementia symptoms (β = −6.57, p = 0.022). The Obesity/High PA group also performed better than the Obesity/Low PA group for memory and orientation (β = 4.43, p = 0.012), social functioning (β = 4.52, p = 0.006), visuo-spatial processing (β = −2.39, p = 0.038), and overall dementia symptoms (β = −7.21, p = 0.016). There were no assessments for which either high PA group performed worse than either Low PA group.
Conclusions
Physical activity may benefit AD-related cognitive function in persons with DS, regardless of obesity status.
World Health Organization. Definition: intellectual disability. Retrieved from World Health Organization Regional Office for Europe website: http://www euro who int/en/what-we-do/health-topics/noncommunicable-diseases/mental-health/news/news/2010/15/childrens-right-to-family-life/definitionintellectual-disability (2014).
2.
EnglundAJonssonBZanderCS, et al.Changes in mortality and causes of death in the Swedish Down syndrome population. Am J Med Genet Part A2013; 161: 642–649.
3.
ForteaJVilaplanaECarmona-IraguiM, et al.Clinical and biomarker changes of Alzheimer's disease in adults with Down syndrome: a cross-sectional study. Lancet2020; 395: 1988–1997.
4.
ForteaJZamanSHHartleyS, et al.Alzheimer's disease associated with Down syndrome: a genetic form of dementia. Lancet Neurol2021; 20: 930–942.
5.
IulitaMFChavezDGChristensenMK, et al.Association of Alzheimer disease with life expectancy in people with Down syndrome. JAMA Network Open2022; 5: e2212910.
6.
RumbleBRetallackRHilbichC, et al.Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease. N Engl J Med1989; 320: 1446–1452.
7.
WisniewskiKEWisniewskiHMWenGY. Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome. Ann Neurol1985; 17: 278–282.
8.
OzatoNSaitouSYamaguchiT, et al.Association between visceral fat and brain structural changes or cognitive function. Brain Sci2021; 11: 1036.
9.
NianogoRARosenwohl-MackAYaffeK, et al.Risk factors associated with Alzheimer disease and related dementias by sex and race and ethnicity in the US. JAMA Neurol2022; 79: 584–591.
10.
DairoYMCollettJDawesH, et al.Physical activity levels in adults with intellectual disabilities: a systematic review. Prev Med Rep2016; 4: 209–219.
11.
O’SheaMO’SheaCGibsonL, et al.The prevalence of obesity in children and young people with Down syndrome. J Appl Res Intellect Disabil2018; 31: 1225–1229.
12.
AgiovlasitisSJinJYunJ. Age-group differences in body mass index, weight, and height in adults with Down syndrome and adults with intellectual disability from the United States. Adapt Phys Activ Q2020; 38: 79–94.
13.
PtomeyLWalpitageDMohseniM, et al.Weight status and associated comorbidities in children and adults with Down syndrome, autism spectrum disorder and intellectual and developmental disabilities. J Intellect Disabil Res2020; 64: 725–737.
14.
LiMGongWWangS, et al.Trends in body mass index, overweight and obesity among adults in the USA, the NHANES from 2003 to 2018: a repeat cross-sectional survey. BMJ Open2022; 12: e065425.
15.
PiercyKLTroianoRPBallardRM, et al.The physical activity guidelines for Americans. JAMA2018; 320: 2020–2028.
16.
ClarkeTNorrisTSchillerJ. Early release of selected estimates based on data from the 2016 National Health Interview Survey. Hyattsville, MD: National Center for Health Statistics, 2017, http://www.cdc.gov/nchs/nhis.htm.
17.
FlemingVPiro-GambettiBPatrickA, et al.Physical activity and cognitive and imaging biomarkers of Alzheimer's disease in Down syndrome. Neurobiol Aging2021; 107: 118–127.
18.
DoddDHelselBBoddeAE, et al.The association of increased body mass index on cardiorespiratory fitness, physical activity, and cognition in adults with Down syndrome. Disabil Health J2023; 16: 101497.
19.
PapeSEBakshRAStartinC, et al.The association between physical activity and CAMDEX-DS changes prior to the onset of Alzheimer’s disease in Down syndrome. J Clin Med2021; 10: 1882.
20.
OppewalAHilgenkampTIM. Is fatness or fitness key for survival in older adults with intellectual disabilities?J Appl Res Intellect Disabil2020; 33: 1016–1025.
21.
LyerlyGWSuiXLavieCJ, et al.The association between cardiorespiratory fitness and risk of all-cause mortality among women with impaired fasting glucose or undiagnosed diabetes mellitus. Mayo Clin Proc2009; 84: 780–786.
22.
Do LeeCBlairSNJacksonAS. Cardiorespiratory fitness, body composition, and all-cause and cardiovascular disease mortality in men. Am J Clin Nutr1999; 69: 373–380.
23.
SuiXLaMonteMJBlairSN. Cardiorespiratory fitness as a predictor of nonfatal cardiovascular events in asymptomatic women and men. Am J Epidemiol2007; 165: 1413–1423.
24.
ChurchTSLaMonteMJBarlowCE, et al.Cardiorespiratory fitness and body mass index as predictors of cardiovascular disease mortality among men with diabetes. Arch Intern Med2005; 165: 2114–2120.
25.
RoidGHPomplunM. The Stanford-binet intelligence scales. New York, NY: The Guilford Press, 2012.
26.
KaufmanASKaufmanNL.Kaufman brief intelligence test. Encyclopedia of Special Education: A reference for the education of children, adolescents, and adults with disabilities and other exceptional individuals, 2013.
27.
HandenBLLottITChristianBT, et al.The Alzheimer's biomarker consortium-Down syndrome: rationale and methodology. Alzheimers Dement (Amst)2020; 12: e12065.
28.
Van HeesVTFangZLangfordJ, et al.Autocalibration of accelerometer data for free-living physical activity assessment using local gravity and temperature: an evaluation on four continents. J Appl Physiol2014; 117: 738–744.
29.
Van HeesVTGorzelniakLDean LeónEC, et al.Separating movement and gravity components in an acceleration signal and implications for the assessment of human daily physical activity. PloS One2013; 8: e61691.
30.
HildebrandMVan HeesVTHansenBH, et al.Age group comparability of raw accelerometer output from wrist- and hip-worn monitors. Med Sci Sports Exerc2014; 46: 1816–1824.
31.
HildebrandMHansenBHvan HeesVT, et al.Evaluation of raw acceleration sedentary thresholds in children and adults. Scand J Med Sci Sports2017; 27: 1814–1823.
32.
DevennyDZimmerliEKittlerP, et al.Cued recall in early-stage dementia in adults with Down's syndrome. J Intellect Disabil Res2002; 46: 472–483.
33.
HartleySLHandenBLDevennyD, et al.Cognitive decline and brain amyloid-β accumulation across 3 years in adults with Down syndrome. Neurobiol Aging2017; 58: 68–76.
34.
BallSLHollandAJTreppnerP, et al.Executive dysfunction and its association with personality and behaviour changes in the development of Alzheimer's disease in adults with Down syndrome and mild to moderate learning disabilities. Br J Clin Psychol2008; 47: 1–29.
35.
WechslerD. Wechsler memory scale. San Antonio, TX: Psychological Corporation, 1945.
36.
HaxbyJV. Neuropsychological evaluation of adults with Down's syndrome: patterns of selective impairment in non-demented old adults. J Intellect Disabil Res1989; 33: 193–210.
37.
BeeryKEBeeryVMI. The Beery-Buktenica developmental test of visual-motor integration. Minneapolis, MN: Pearson, 2004.
38.
Krinsky-McHaleSJZigmanWBLeeJH, et al.Promising outcome measures of early Alzheimer's dementia in adults with Down syndrome. Alzheimers Dement (Amst)2020; 12: e12044.
39.
TempleVJozsvaiEKonstantareasM, et al.Alzheimer dementia in Down's syndrome: the relevance of cognitive ability. J Intellect Disabil Res2001; 45: 47–55.
40.
EvenhuisHM. The dementia questionnaire for people with learning disabilities. In: PrasherVP (eds) Neuropsychological assessments of dementia in Down syndrome and intellectual disabilities. Cham, Switzerland: Springer International Publishing AG, 2018, pp.43–56.
41.
SilvermanWKrinsky-McHaleSJLaiF, et al.Evaluation of the national task group-early detection screen for dementia: sensitivity to ‘mild cognitive impairment’ in adults with down syndrome. J Appl Res Intellect Disabil2021; 34: 905–915.
42.
Elliott-KingJShawSBandelowS, et al.A critical literature review of the effectiveness of various instruments in the diagnosis of dementia in adults with intellectual disabilities. Alzheimers Dement (Amst)2016; 4: 126–148.
43.
TolppanenA-MSolomonAKulmalaJ, et al.Leisure-time physical activity from mid-to late life, body mass index, and risk of dementia. Alzheimers Dement2015; 11: 434–443.e436.
44.
NormanABelloccoRVaidaF, et al.Total physical activity in relation to age, body mass, health and other factors in a cohort of Swedish men. Int J Obes2002; 26: 670–675.
45.
GodfreyALordSGalnaB, et al.The association between retirement and age on physical activity in older adults. Age Ageing2014; 43: 386–393.
46.
PhillipsACHollandAJ. Assessment of objectively measured physical activity levels in individuals with intellectual disabilities with and without Down's syndrome. PloS One2011; 6: e28618.
47.
Tudor-LockeCBarreiraTVSchunaJMJr. Comparison of step outputs for waist and wrist accelerometer attachment sites. Med Sci Sports Exerc2015; 47: 839–842.
